OptimizeRx OPRX Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by OptimizeRx in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about OptimizeRx's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OptimizeRx's total liabilities & equity?
- OptimizeRx (OPRX) reported total liabilities & equity of $167.26M in Q1 2026.
- How has OptimizeRx's total liabilities & equity changed year-over-year?
- OptimizeRx's total liabilities & equity decreased by 0.3% year-over-year, from $167.77M to $167.26M.
- What is the long-term trend for OptimizeRx's total liabilities & equity?
- Over 5 years (2020 to 2025), OptimizeRx's total liabilities & equity has grown at a 24.0% compound annual growth rate (CAGR), from $60.33M to $176.92M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.